You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -152.1% | 16.1% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -7.0 | 21.6 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 48.5 | 3.5 |
| Price / Book value | 55.6 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (€m) |
Pre-tax (€m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | 17.91 | -0.91 | €-0.01 | -21.2 | 0.0 | n/a | n/a | 0.0% |
| 2017-12-31 | 17.41 | -1.80 | €-0.03 | -4.7 | 0.0 | n/a | n/a | 0.0% |
| 2018-12-31 | n/a | -1.66 | €-7.85 | 0.0 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | 3.84 | -6.62 | €-0.04 | -1.4 | 0.0 | n/a | n/a | 0.0% |
| Open Orphan confirms first volunteer dosing of needle-free Covid vaccine Sharecast News | 11 Jan |
|---|---|
| Open Orphan renews contract with top-3 pharma client Sharecast News | 22 Dec |
| Open Orphan upbeat on progress with nasal Covid-19 vaccine Sharecast News | 14 Dec |
| First volunteer dosed in COVID-19 clinical trial | 11-Jan-21 07:03 |
|---|---|
| Holding(s) in Company | 06-Jan-21 16:29 |
| Contract renewal with top-3 pharmaceutical client | 06-Jan-21 07:03 |
| Rule 19.6(c) Confirmation | 31-Dec-20 07:04 |
| Contract renewal with top-3 pharmaceutical client | 22-Dec-20 07:03 |